Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

Search results

1-10 results from 1000 for query «approval»

14 December, 2018 12:38 PM India Post announces full-fledged entry into e-commerce

"India Post is open for registration of all vendors for e-commerce business. It will pick up products from vendor and deliver to doorstep of customers," Manoj Sinha said. India Post announced full-fledged entry into e-commerce business, where it will leverage its parcel business for end-to-end delivery of products. "We have simplified decision-making 25

14 December, 2018 12:32 PM United Airlines To Launch Daily Flight From Delhi To San Francisco

United Airline's new route to San Francisco will be the airline's third daily nonstop service from India, the airline said in a statement. Airline major United Airlines on Thursday announced it will introduce a new daily nonstop seasonal service between New Delhi and San Francisco from December 7, 2019 -- subject to government approval. "United's new route 30

14 December, 2018 11:37 AM Understanding the Kotak-RBI battle – Letter, spirit, rules and a court petition

We examine the complications and implications – essentially the answer to the question: What is this Kotak’s Natak? Kotak Bank which was built by Uday Kotak was asked by RBI to pare down its promoter stake way back in 2012. THis is normal, as part of RBI norms, to “broadbase� the shareholding and to restrict individuals from holding large stakes 69

13 December, 2018 12:35 PM Saudi Arabia likely to make biggest investment in Pakistan's history

Pakistan finance minister Asad Umar has said the package would be announced soon. Islamabad: A Pakistan minister on Thursday said that an incoming investment package from Saudi Arabia promises to be "the biggest foreign investment in the country`s history". Asad Umar, while addressing an event in Islamabad, said that the package would be announced soon, reports 34

13 December, 2018 12:11 PM Lupin gets USFDA nod for multiple sclerosis drug

Drug maker Lupin said it has received a tentative approval from the US health regulator to market Dimethyl Fumarate delayed release capsules used to treat multiple sclerosis. The drug is indicated for the treatment of patients with relapsing forms of multiple sclerosis. The company has received the tentative approval from the United States Food and Drug Administration 31

13 December, 2018 7:01 AM Govt working on four-pronged strategy to revive Air India: Report

The four elements of the strategy are – financial package, organizational and governance reforms, refresh strategy and strengthen workforce. The government is working on a four-pronged strategy to revive Air India after a failed attempt to sell off a 76 percent stake in the national carrier, reports The Economic Times. The strategy involves providing 36

12 December, 2018 3:50 AM Zydus Wellness gains 2% on CCI nod to acquire Heinz India

Shares of Zydus Wellness gained 2.3 percent in the early trade on Wednesday after company received CCI approval for acquisition of businesses of Heinz. The Competition Commission of India (CCI) has granted approval for the company's acquisition of Heinz India jointly with Cadila Healthcare. The definitive agreement in relation to this acquisition was signed 44

11 December, 2018 5:39 AM Strides Pharma wipes losses, up 3.4% as JV gets US FDA nod for tapeworm infection drug

The joint venture -- Strides Vivimed -- received approval from the US Food and Drug Administration (FDA) for its Albendazole Tablets USP 200 mg Shares of Strides Pharma Science rose as much as 3.4 percent after the company's joint venture received the US FDA's approval for its tapeworm infection treatment drug. The joint venture -- Strides Vivimed 59

10 December, 2018 1:27 PM Lupin gets tentative USFDA nod for generic Apixaban tablets

Drug firm Lupin said it has received a tentative nod from the US health regulator to market its generic Apixaban tablets. The company has received the tentative approval from the United States Food and Drug Administration (USFDA) to market Apixaban tablets in the strengths of 2.5 mg and 5 mg, Lupin said in a filing to BSE. The product is a generic version 53

10 December, 2018 5:27 AM Alembic Pharmaceuticals gains on USFDA approval; NCD Committee meet on Dec 14

Shares of Alembic Pharmaceuticals has turned positive after it received approval from the US Food & Drug Administration (USFDA). The company has received approval from USFDA for its abbreviated new drug application (ANDA) Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1 %. The approved ANDA is therapeutically equivalent to the reference listed 66